Brief: Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results And Provides Corporate Update

Corbus Pharmaceuticals Holdings

09/05/2023 14:07

Corbus Pharmaceuticals Holdings Inc  CRBP.O :
    * CORBUS PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * CORBUS PHARMACEUTICALS HOLDINGS INC - CRB-701 PHASE 1 DOSE
ESCALATION STUDY ONGOING IN PATIENTS WITH ADVANCED SOLID TUMORS
IN CHINA
    * CORBUS PHARMACEUTICALS- AS OF MARCH 31, 2023, HAS $44.2
MILLION
OF CASH AND INVESTMENTS ON HAND WHICH IS EXPECTED TO FUND
OPERATIONS THROUGH Q2 OF 2024
    * CORBUS PHARMACEUTICALS HOLDINGS INC -QTRLY NET LOSS PER
DILUTED
SHARE OF $4.24

Source text for Eikon:  ID:nPn605tt1a 
Further company coverage:  CRBP.O